Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT03572127Not ApplicableCompleted

Mycoprotein, Resistance Training, and Hypertrophy

Role: collaborator

NCT05584358Not ApplicableCompleted

Protein Extrusion and Postprandial Amino Acid Handling

Role: collaborator

NCT04894747Not ApplicableCompleted

Mycoprotein and Pea Protein Blend and Muscle Protein Synthetic Response

Role: collaborator

NCT04084652Not ApplicableCompleted

Mycoprotein and Muscle Protein Synthetic Response

Role: collaborator

NCT03944421Not ApplicableCompleted

The Effects of Replacing Red and Processed Meat With Quorn on Biomarkers of Gut Health

Role: collaborator

NCT04084639Not ApplicableCompleted

Mycoprotein Consumption and Glucose Absorption

Role: collaborator

All 6 trials loaded